REFERENCES
- Spontnitz WD, Burks SG. Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost 2010;16:497–514.
- Achneck HE, Sileshi B, Jamiolkowski RM, A comprehensive review of topical hemostatic agents. Ann Surg 2010;251:217–228.
- Boucher BA, Traub O. Achieving hemostasis in the surgical field. Pharmacotherapy 2009;29:S2–S7.
- Oz MC, Cosgrove DM 3rd, Badduke BR, Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 2000;69:1376–1382.
- Raga F, Sanz-Cortes M, Bonilla F, et al. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril 2009;92:356–360.
- Nasso G, Piancone F, Bonifazi R, Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009;88(5):1520–1526.
- Mozet C, Prettin C, Dietze M, Use of floseal and effects on wound healing and pain in adults undergoing tonsillectomy: Randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol 2011 Dec 30. [Epub ahead of print].
- Chapman WC, Singla N, Genyk Y, A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surgeons 2007;205(2):256–265.
- Doria C, Fischer CP, Wood CG, Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin 2008;24:785–794.
- Lawson JH, Lynn KA, Vanmatre RM, Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg 2005;79:1037–1038.
- Djagny KB, Wang Z, Xu S. Gelatin: A valuable protein for food and pharmaceutical industries: Review. Crit Rev Food Sci Nutr 2001;41:481–492.
- FLOSEAL VH S/D Instructions for Use. Deerfield, IL: Baxter Healthcare Corporation; 2005.
- SURGIFLO Instructions for Use. Somerville, NJ: J & J Wound Management; 2008.
- EVITHROM Prescribing Information. Somerville, NJ: J & J Wound Management; 2007.
- Adams G, Manson J Hasselblad V, Acute in-vivo evaluation of bleeding with GelfoamTM plus saline and GelfoamTM Plus human thrombin using a liver square lesion model in swine. J Thromb Thrombolysis 2009;28:1–5.
- Thornton JA. Estimation of blood loss during surgery. Ann R Coll Surg Engl 1963;33:164–174.
- Lewis J. Pigs. In: Comparative Hemostasis in Vertebrates. Lewis J, New York: Plenum Press; 1996:286–297.
- Hahn N, Popov-Cenic S, Dorer A. Basic values of blood coagulation parameters in pigs (Sus scrofa domesticus) [German]. Berl Munch Tierarztl Wochenschr 1996;109:23–27.
- Bull BS, Huse WM, Brauer FS, Heparin therapy during extracorporeal circulation II: The use of a dose response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975;69:685–689.
- Fitzgerald DJ, Patel A, Body SC, The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion 2009;24:93–96.
- Eastoe JE. The amino acid composition of mammalian collagen and gelatin. Biochem J 1955;61:589–600.
- Mosesson MW, DiOrio JP, Müller MF, Studies on the ultrastructure of fibrin lacking fibrinopeptide B (β-Fibrin). Blood 1987;69:1073–1081.
- Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992;63:111–128.
- Oswald MW, Hunt HH, Lazarchick J. Normal range of plasma fibrinogen. Am J Med Technol 1983;49:57–59.
- Shapiro SS, Martinez J. Human prothrombin metabolism in normal man and in hypocoagulable subjects. J Clin Invest 1969;48:1292–1298.
- Nogueira L, Katz D, Pinochet R, Comparison of gelatin matrix-thrombin sealants used during laparoscopic partial nephrectomy. BJU Int 2008;102:1670–1674.